Review Article
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Table 2
Gene modification in MSC transplantation for treating MI.
| Gene name | Disease | Model | Modification | Gene function | Reference |
| Hsp27 | MI | Rat | Overexpression | Viability↑; apoptosis↓ | [60] | MicroRNA-133 | MI | Rat | Overexpression | Survival ↑ | [61] | SDF-1α | MI | Rat | Overexpression | Homing↑ | [62] | CAMKK1 | MI | Rat | Overexpression | Angiogenesis↑; infarct size↓; ejection fraction↑ | [63] | eNOS | MI | Rat | Overexpression | Infarct size↓; angiogenesis↑ | [64] | Akt1 | MI | Rat | Overexpression | Cardiac function↑ | [45] | PKG1α | MI | Rat | Overexpression | Survival↑; angiogenesis↑ | [65] | Caspase 8 | MI | Rat | Silence | Cardiac fibrosis↓; survival↑ | [66] | SIRT1 | MI | Rat | Overexpression | Cardiac remodeling↓; angiogenesis↑ | [67] | Netrin-1 | MI | Rat | Overexpression | Survival↑; migration | [68] | FGF4-bFGF | MI | Rat | Overexpression | Survival↑; microvascular density↑; cardiac fibrosis↓ | [69] | MicroRNA-377 | MI | Rat | Knockdown | Angiogenesis↑ | [70] | PKCɛ | MI | Rat | Overexpression | Survival ↑; infarct size ↓apoptosis ↓ | [71] | Trx1 | MI | Rat | Overexpression | Angiogenesis↑ | [72] | BCL2L1 (Bcl-xL) | MI | Rat/MSC culture | Overexpression | Apoptosis↓; angiogenesis↑ | [73] | MDK | MI | Rat/MSC culture | Overexpression | Apoptosis↓; cardiac function↑ | [74] | miR-23a | MI | Rat/MSC culture | Overexpression | Apoptosis↓; infarct size↓ | [75] | miR Let-7b | MI | Rat/MSC culture | Overexpression | Cardiac function↓; infarct size↓; angiogenesis ↑ | [76] | VEGF | MI | Rat/MSC culture | Overexpression | Survival ↑; angiogenesis ↑ | [77] | HIF-1A | MI | Rat/MSC culture | Overexpression | Paracrine↑; angiogenesis↑; migration↑ | [78] | KLK1 (tissue kallikrein) | MI | Rat/MSC culture | Overexpression | Apoptosis ↓; apoptosis↓ | [79] | PHD2 | MI | Mouse | Silence | Survival↑; apoptosis↓;scar size↓ | [80] | ecSOD | MI | Mouse | Overexpression | Infarction size↓; apoptosis↓; survival.↑ | [81] | MIR1-1 (miR-1) | MI | Mouse | Overexpression | Survival↑ | [82] | HGF | MI | Mouse | Overexpression | Angiogenesis↑; apoptosis↓ | [83] | ILK | MI | Porcine | Overexpression | Homing↑; LVEF↑; myocardial remodeling↓ | [84] | IGF-1 | MI | Porcine | Overexpression | Angiogenesis ↑ | [85] | GLP-1 | MI | Porcine | Overexpression | Angiogenesis ↑ | [86] | VEGF (165) | MI | Ovine | Overexpression | Infarct size↓; left ventricular function↑ | [87] | hRAMP1 | MI | Rabbit | Overexpression | Infarct size↓ | [88] | SOD2 | — | MSC culture | Overexpression | Apoptosis↓ | [56] | miR-210 | — | MSC culture | Overexpression | Apoptosis↓; survival↑ | [88] | CXCL12 | — | MSC culture | Overexpression | Apoptosis↓; proliferation↑ | [89] |
|
|
MDK: midkine; Trx1: thioredoxin-1; PKCɛ: protein kinase C ɛ; IGF-1: insulin-like growth factor-1; Hsp27: exogenous heat shock protein 27; SOD2: manganese superoxide dismutase; OH-1: heme oxygenase; CXCR4: CXC chemokine receptor 4; CAMKK1: calcium/calmodulin-dependent protein kinase kinase-1;eNOS:endothelial nitric oxide synthases; ILK: integrin-linked kinase; Nrf2: nuclear factor- (erythroid-derived 2-) like 2; PHD2: prolyl hydroxylase domain protein 2; GLP-1: glucagon-like peptide-1; SIRT1: silent mating type information regulation 2 homolog 1; FGF4: fibroblast growth factor 4; bFGF: basic fibroblast growth factor; ecSOD: extracellular superoxide dismutase; RAMP1: receptor activity-modifying protein 1; PKG1α: protein kinase type 1α.
|